NIH-funded research R21 grant

Investigating how a specific gene affects brain development in children with Down syndrome

Official title: Establishing the role of Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A trisomy in juvenile plasticity impairment in Down Syndrome

Funded at New York University School of Medicine · NIH-11070407 · Data updated 2026-11-12

This study is looking at how certain genes, especially one called DYRK1A, affect brain development in kids with Down syndrome, using mice to learn more about how we might help improve thinking skills in these children.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startApril 15, 2024
Project endMarch 31, 2026
Funding year2025
Award (this year)$211,875
NIH project number5R21NS137191-02
Project IDNIH-11070407 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children diagnosed with Down syndrome who may experience cognitive delays.

Less likely to help

Patients without Down syndrome or those who do not exhibit cognitive impairments related to trisomy may not benefit from this research.

What this research studies

This research explores the genetic and molecular factors that contribute to developmental delays in individuals with Down syndrome, focusing on how trisomy affects brain development during critical juvenile periods. Using a mouse model, the study examines how the gene DYRK1A influences brain plasticity, particularly in response to visual stimuli. By understanding these mechanisms, the research aims to identify potential therapeutic targets that could improve cognitive function in affected individuals.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for enhancing cognitive abilities in children with Down syndrome.

How similar studies have gone: Previous research has shown promising results in understanding genetic influences on cognitive function in Down syndrome, suggesting that this approach may yield valuable insights.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: William, Christopher Maged — New York University School of Medicine
  • Study coordinator: William, Christopher Maged

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.